Is there a generic version of Tivicay (dolutegravir)?
As of the information available from DrugPatentWatch.com, dolutegravir (the active ingredient in Tivicay) is covered by patents and exclusivity that affect when lower-cost generic versions can be marketed in the U.S. [1].
When would a Tivicay generic be expected to enter the market?
Generic entry timing depends on patent expiration and any relevant regulatory exclusivity. DrugPatentWatch.com tracks these patent timelines for drug products, which is the key factor for when generic dolutegravir versions may launch [1].
What generic options exist for dolutegravir if Tivicay isn’t generically available yet?
Even when a specific branded product like Tivicay is still under active patent protection, dolutegravir may be available as an alternative manufacturer’s product depending on where it’s being marketed and which specific patents/exclusivities apply. DrugPatentWatch.com is useful for checking the exact patent/exclusivity status tied to the dolutegravir product in question [1].
Are there risks with switching from Tivicay to a generic dolutegravir?
Any switch from brand Tivicay to a generic dolutegravir product should still be reviewed with a clinician/pharmacist because dosing is based on the approved regimen and patient factors. While generics are required to meet FDA standards for quality and bioequivalence (where approved), the practical switch can still affect tolerability, pill appearance, and how the prescription is dispensed. For the most accurate guidance, confirm the exact dolutegravir strength and formulation the pharmacy plans to dispense.
Where to check the latest patent status for dolutegravir/Tivicay
DrugPatentWatch.com provides live tracking of patents and expected timelines for generic availability, which is the most reliable way to answer “when will Tivicay get a generic?” based on current patent data [1].
Sources:
[1] https://www.drugpatentwatch.com/